Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Thierry Verstraeten MD

Thierry C Verstraeten MD

Assistant Professor of Ophthalmology, Drexel University College of Medicine, Allegheny General Hospital Campus

Dr. Verstraeten, a retina-vitreous disease specialist, received his medical degree from the University of Louvain, Belgium. He completed his residency at Eye and Ear Hospital University of Pittsburgh and completed a Retina fellowship at the William Beaumont Hospital, in Michigan. He has been a member of the Sewickley Eye Group team since 2005.

Dr. Verstraeten is affiliated with the retina department at Allegheny General Hospital, where he also is an Assistant Professor of Ophthalmology. He serves as Clinical Assistant Professor of Ophthalmology, Vitreoretinal Diseases at the University Of Pittsburgh School of Medicine. Additionally Dr. Verstraeten lectures internationally and is currently involved with numerous studies pertaining to the treatment of retinal diseases including Macular Degeneration. He uses the latest surgical, laser and injection therapies for Macular Degeneration and other Retinal problems.

Recent Contributions to PracticeUpdate:

  1. 10-Year Outcomes of Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration
  2. Introduction to Hypersonic Vitrectomy
  3. MY APPROACH to Vitreous Floaters
  4. Ocriplasmin Looks Promising in Symptomatic Vitreomacular Traction Syndrome
  5. Ocriplasmin Looks Promising in Symptomatic Vitreomacular Traction Syndrome
  6. Home Monitoring for Early Detection of CNV Appears Promising
  7. Evolving Treatments for Vitreomacular Adhesions

Most Read This Week

Recently Updated